SKI Market

Indian Indices

Sensex

85,343.42 122.82
( 0.14%)

Global Indices

Nasdaq

48,085.52 -302.55
(-0.63%)

Dow Jones

6,867.73 -49.51
(-0.72%)

Hang Seng

50,384.39 -142.53
(-0.28%)

Nikkei 225

9,931.38 -9.33
(-0.09%)

Forex

USD-INR

89.84 -0.06
(-0.06%)

EUR-INR

105.67 -0.12
(-0.11%)

GBP-INR

121.20 -0.12
(-0.10%)

JPY-INR

0.58 0.00
(-0.05%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Pro Fin Capital Services Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

511557

INE732K01027

2.9151584

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

16.2

244.74

EPS(TTM)

Face Value()

Div & Yield %

0.51

Back

Concord Drugs consolidated net profit rises 375.00% in the September 2025 quarter

Nov 14,2025

Net profit of Concord Drugs rose 375.00% to Rs 0.19 crore in the quarter ended September 2025 as against Rs 0.04 crore during the previous quarter ended September 2024. Sales declined 16.83% to Rs 10.28 crore in the quarter ended September 2025 as against Rs 12.36 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	10.28	12.36	-17
OPM %	10.70	7.12	-
PBDT	0.61	0.41	49
PBT	0.27	0.07	286
NP	0.19	0.04	375

85,343.42 122.82 ( 0.14%)

48,085.52 -302.55 (-0.63%)

6,867.73 -49.51 (-0.72%)

50,384.39 -142.53 (-0.28%)

9,931.38 -9.33 (-0.09%)

89.84 -0.06 (-0.06%)

105.67 -0.12 (-0.11%)

121.20 -0.12 (-0.10%)

0.58 0.00 (-0.05%)